Linde Healthcare Previews Leading Respiratory Products at AARC Congress 2022

Oct 17, 2022, 10:04 AM by User Not Found
Linde Healthcare is excited to attend AARC Congress 2022, where our representatives will be exhibiting our leading respiratory products, including Linde’s line of GRAB ‘N GO® gas delivery systems as well as our NOXIVENT® gas and NOxBOXi® system for inhaled nitric oxide therapy.

Join Linde November 9–12 in New Orleans for AARC Congress 2022, an annual networking and educational event for respiratory therapists from around the world, offering cutting-edge lectures by the top leaders in the industry, held at the New Orleans Ernest N. Morial Convention Center.

Linde Healthcare is excited to be attending this year’s event (booth #319) where our representatives will be exhibiting demonstrations and previews of our leading respiratory products. Linde Healthcare, formerly Praxair Healthcare Services, is committed to bringing innovative medical gas and related services and equipment to our healthcare customers. With Linde, you can look forward to reliability and support from a global leader in healthcare.  Linde AARC 2022 Show Grab'n Go

Ask Us About Linde’s Line of GRAB ‘N GO® Gas Delivery Systems  

Being exhibited at this year’s event is Linde’s line of GRAB ‘N GO® gas delivery systems. With their all-in-one design,  Linde’s GRAB ‘N GO gas delivery systems help users of Medical Oxygen USP and other medical gases simplify the use of portable cylinders. The increased ease of use makes a positive difference in the daily activities of health care professionals, allowing them to spend less time managing gases and more time focusing on patient needs. 

Visit our Linde Healthcare site here to learn more about Linde’s GRAB ‘N GO gas delivery systems, including GRAB ‘N GO Air, GRAB ‘N GO Heliox and GRAB ‘N GO Digital gas delivery systems.  

LearnMoreGrabNGo

NOXIVENT® (Nitric Oxide) Gas and NOxBOXi® System for Inhaled Nitric Oxide Therapy

NOXIVENT® (nitric oxide) gas for inhalation is a vasodilator indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents. 

The NOxBOXi® delivery device provides intelligent nitric oxide delivery with precise real-time monitoring of nitric oxide, nitrogen dioxide, and oxygen through a touch screen with a step-by-step guided interface to enable ease of use. It is designed for in-hospital use, with portable detachable head unit to provide uninterrupted treatment during transit and transfer situations and may be used with invasive and non-invasive ventilation.

To learn more about these products, contact us at 1-833-669-8368 (1-833-NOX-VENT) or email noxiventUS@Linde.com.  See Important Safety Information.

LearnMoreNoxivent  Lidne conference_exhibition6 AARC 2022 Show


Save the Date and Join Us

All official Congress pre-courses, lectures, and exhibitions will take place at the Ernest N. Morial Convention Center, 900 Convention Center Boulevard, New Orleans, Louisiana 70130. We are looking forward to attending AARC Congress 2022 with a chance to connect with our valued customers. If you’re looking to gain invaluable insights and best practices that can help you succeed in this ever-changing healthcare landscape, save the date and join us!  

_____________________________________________________________________________________________

 

NOXIVENT Gas Selected Safety Information

Contraindications: Noxivent is contraindicated in neonates dependent on right-to-left shunting of blood.
Rebound: Abrupt discontinuation of Noxivent may lead to worsening oxygenation and increasing pulmonary artery pressure.
Methemoglobinemia: Methemoglobin levels increase with the dose of Noxivent; it can take 8 hours or more before steady-state methemoglobin levels are attained. If methemoglobin levels do not resolve with decrease in dose or discontinuation of Noxivent, additional therapy may be warranted to treat methemoglobinemia.
Airway injury from Nitrogen Dioxide: Monitor nitrogen dioxide (NO2) levels. Nitrogen dioxide may cause airway inflammation and damage to lung tissue.
Heart Failure: In patients with pre-existing left ventricular dysfunction, Noxivent may increase pulmonary capillary wedge pressure leading to pulmonary edema.
Adverse Reactions: The most common adverse reaction of Noxivent is hypotension.
Drug Interactions: Nitric Oxide donor compounds may increase the risk of developing methemoglobinemia.
Administration: Use only with a calibrated NOxBOXi delivery system operated by trained personnel. Only validated ventilator systems should be used in conjunction with Noxivent.
Please see full Noxivent prescribing information for additional Noxivent safety and risk information.
 

NOxBOXi Nitric Oxide Delivery System Indication

NOxBOXi Nitric Oxide Delivery system is intended for use by healthcare professionals for the delivery and monitoring of a constant (use set) concentration of nitric oxide (NO) and the monitoring of NO2 and O2 in the inspiratory ventilator lines of a patient undergoing nitic oxide therapy (iNO). The NOxBOXi Nitric Oxide Delivery System must only be used in accordance with the indications, contraindications, warnings, and precautions described in the nitric oxide drug packaging inserts and labelling (currently neonates). Refer to this material prior to use.